21 – 30 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
(
- Contribution to journal › Article
- 2013
-
Mark
Can SLC19A1 80G>A Polymorphisms Predict Risk of Extremely Delayed MTX excretion After High Dose of Methotrexate?
(
- Contribution to journal › Letter
-
Mark
Hospital-based home care for children with cancer: Feasibility and psychosocial impact on children and their families
(
- Contribution to journal › Article
- 2011
-
Mark
Hospital-Based Home Care for Children With Cancer
(
- Contribution to journal › Scientific review
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
(
- Contribution to journal › Article
- 2010
-
Mark
Hospital-Based Home Care For Children With Cancer
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Poor Treatment Compliance in Children With Down Syndrome and Acute Lymphoblastic Leukemia
(
- Contribution to journal › Letter
-
Mark
Individualized 6-Mercaptopurine Increments During Consolidation Treatment Of Lower Risk Childhood All
(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
(
- Contribution to journal › Article
- 2001
-
Mark
Drug monitoring of azathioprine (AZA) and 6-mercaptopurine (6-MP) among adult patients with inflammatory bowel disease (IBD)
2001) Digestive Disease Week and the 102nd Annual Meeting of the American Gastroenterological Association In Gastroenterology 120(5, Suppl. 1). p.623-623(
- Contribution to journal › Published meeting abstract